These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 15852889)

  • 21. Natriuretic peptides: putting the evidence into practice.
    Andrade A; Sharar H
    Can J Cardiovasc Nurs; 2008; 18(4):34-9. PubMed ID: 19093420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides.
    Pfister R; Schneider CA
    Eur Heart J; 2009 Feb; 30(3):382-3; author reply 383. PubMed ID: 19109350
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnosis of heart failure.
    Chang AM; Maisel AS; Hollander JE
    Heart Fail Clin; 2009 Jan; 5(1):25-35, vi. PubMed ID: 19026383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice.
    Daniels LB; Maisel A
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):414-5. PubMed ID: 16721203
    [No Abstract]   [Full Text] [Related]  

  • 25. The coming of age of natriuretic peptides: the emperor does have clothes!
    Maisel A
    J Am Coll Cardiol; 2006 Jan; 47(1):61-4. PubMed ID: 16386665
    [No Abstract]   [Full Text] [Related]  

  • 26. [Will the therapy of chronic heart failure be guided by plasma levels of natriuretic peptides?].
    Hradec J; Krupicka J; Janota T
    Cas Lek Cesk; 2009; 148(8):383-8. PubMed ID: 19899725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The heart as an endocrine system.
    Grewal AS; Fitzpatrick M; Stansbury L; Grigore AM
    Int Anesthesiol Clin; 2012; 50(2):111-27. PubMed ID: 22481559
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of soluble glycoprotein 130 and cardiac natriuretic peptides as long-term predictors of heart failure progression.
    Gwechenberger M; Pacher R; Berger R; Zorn G; Moser P; Stanek B; Huelsmann M
    J Heart Lung Transplant; 2005 Dec; 24(12):2190-5. PubMed ID: 16364870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical biochemistry: heart hormones. The Danish Society of Biochemistry].
    Gøtze JP; Rehfeld JF
    Ugeskr Laeger; 2004 Mar; 166(12):1109. PubMed ID: 15067768
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of b-type natriuretic peptide in heart failure management.
    Newton PJ; Betihavas V; Macdonald P
    Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology of acute decompensated heart failure.
    Summers RL; Amsterdam E
    Heart Fail Clin; 2009 Jan; 5(1):9-17, v. PubMed ID: 19026381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary diagnosis of heart failure in ambulatory and hospitalized patients].
    Störk S; Frantz S; Bauersachs J; Ertl G; Angermann CE
    Dtsch Med Wochenschr; 2008 Mar; 133(13):636-41. PubMed ID: 18351507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-type natriuretic peptides: applications for heart failure management in 2005.
    Troughton RW; Richards M
    Intern Med J; 2005 Jul; 35(7):377-9. PubMed ID: 15958104
    [No Abstract]   [Full Text] [Related]  

  • 34. Evolution of amino-terminal pro-B type natriuretic peptide testing in heart failure.
    Januzzi JL; Bayes-Genis A
    Drug News Perspect; 2009 Jun; 22(5):267-73. PubMed ID: 19609464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-type natriuretic peptide and the stressed heart.
    Nohria A; Givertz MM
    J Am Coll Cardiol; 2006 Feb; 47(4):749-51. PubMed ID: 16487839
    [No Abstract]   [Full Text] [Related]  

  • 36. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment].
    Dahlström U
    Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of natriuretic peptides in the intensive care unit.
    Pirracchio R; Logeart D; Noveanu M; Mebazaa A; Mueller C
    Curr Opin Crit Care; 2008 Oct; 14(5):536-42. PubMed ID: 18787446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.
    Ray P; Delerme S; Jourdain P; Chenevier-Gobeaux C
    QJM; 2008 Nov; 101(11):831-43. PubMed ID: 18664534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diastolic heart failure -- diagnostics].
    Schmidt AG; Pieske B
    Dtsch Med Wochenschr; 2005 May; 130(19):1208-12; quiz 1217-20. PubMed ID: 15875263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.